These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3362823)

  • 21. Problems of short-course chemotherapy still awaiting solution.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):191-2. PubMed ID: 2999964
    [No Abstract]   [Full Text] [Related]  

  • 22. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB; Mozhokina GN; Kunichan AD; Elistratova NA; Perel'man MI
    Probl Tuberk; 2000; (5):35-9. PubMed ID: 11077850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of short-course chemotherapy in Romania.
    Anastasatu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):178-81. PubMed ID: 2999961
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results and aspects of the use of regimens of short-term antitubercular chemotherapy (3+3) in a program of the Cluj County region].
    Petrescu G; Gloabă L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):237-47. PubMed ID: 2855669
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results obtained with the first group of tuberculosis patients included in short-duration intensive treatment].
    Jugănaru V; Dănilă F; Niţu E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):181-4. PubMed ID: 2555906
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative evaluation of tuberculosis therapy regimens in treating patients with destructive pulmonary tuberculosis].
    Berezovskiĭ BA; Marchak VV; Shepetovskaia TA; Zaĭkov SV; Nagornaia EG
    Probl Tuberk; 1985; (10):28-30. PubMed ID: 4070200
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness of chlorprothixene in the combined treatment of pulmonary tuberculosis patients].
    Gunich LA; Vishnevskiĭ BI; Volkon VM
    Probl Tuberk; 1986; (8):35-9. PubMed ID: 3774792
    [No Abstract]   [Full Text] [Related]  

  • 28. [Specific and nonspecific immunity factors in pulmonary tuberculosis under chemo- and tuberculin therapy].
    Dzholdubaev YD
    Zdravookhr Kirg; 1980; (1):43-6. PubMed ID: 6103614
    [No Abstract]   [Full Text] [Related]  

  • 29. [Use of hyaluronidase in the complex treatment of tuberculosis].
    Khitrina GV
    Probl Tuberk; 1973; 51(6):37-41. PubMed ID: 4764123
    [No Abstract]   [Full Text] [Related]  

  • 30. [Certain pharmacotherapeutic properties of heparin and its importance in complex treatment of tuberculosis (literature review)].
    Puzik VI; Makinskiĭ AI
    Probl Tuberk; 1974; (11):14-22. PubMed ID: 4155799
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current aspects of pathogenetic therapy in tuberculosis].
    Balasaniants GS; Sukhanov DS
    Ter Arkh; 2011; 83(8):21-4. PubMed ID: 21961327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Conclusions drawn about the current situation of antitubercular chemotherapy in Romania based on the 1987 national evaluation questionnaire].
    Anastasatu C; Corlan E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(2):157-68. PubMed ID: 2555900
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of patients with pulmonary tuberculosis with antitubercular preparations and levamisole].
    Feuereisl R; Papezová E
    Probl Tuberk; 1988; (3):31-3. PubMed ID: 3290887
    [No Abstract]   [Full Text] [Related]  

  • 34. [The use of antioxidants and antihypoxants in tuberculosis (a review of the literature)].
    Skakun NP
    Vrach Delo; 1991 Mar; (3):52-6. PubMed ID: 2042350
    [No Abstract]   [Full Text] [Related]  

  • 35. [Short-term treatment of pulmonary tuberculosis].
    Karuga WK
    Bull Int Union Tuberc; 1974; 49(1):388-97. PubMed ID: 4143178
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antioxidants in the combined therapy of patients with chronic destructive pulmonary tuberculosis].
    Ivanova LA; Pavlova MV; Archakova LI
    Ter Arkh; 1994; 66(11):54-6. PubMed ID: 7900021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Control over treatment efficacy in pulmonary tuberculosis patients by determining the amount of nucleic acids in the blood].
    Safarian MD; Varosian MA; Karapetian ET
    Vrach Delo; 1990 Dec; (12):42-4. PubMed ID: 1708561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Short-term anti-tuberculosis treatment].
    Pacheco CR; Ramos J; Herrera M; Blancarte L; Jiménez H
    Gac Med Mex; 1981 Jan; 117(1):35-9. PubMed ID: 7262488
    [No Abstract]   [Full Text] [Related]  

  • 39. [Morpho-histochemical study of the processes of healing of tuberculosis during treatment with streptomycin and hyaluronidase].
    Volotnikova VA; El'shanskaia MP
    Probl Tuberk; 1975; (12):58-64. PubMed ID: 1221426
    [No Abstract]   [Full Text] [Related]  

  • 40. Short-course chemotherapy for tuberculosis.
    Ng HK
    Xianggang Hu Li Za Zhi; 1984 Nov; (37):26-31. PubMed ID: 6241591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.